Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016
Summary
Global Markets Directs, Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Chronic Obstructive Pulmonary Disease (COPD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects.
Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=719498
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Click to submit Query/ Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=719498
Table of Contents
Table of Contents 2
Introduction 7
Chronic Obstructive Pulmonary Disease (COPD) Overview 8
Therapeutics Development 9
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics under Development by Companies 11
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics under Investigation by Universities/Institutes 21
Chronic Obstructive Pulmonary Disease (COPD) Pipeline Products Glance 22
Chronic Obstructive Pulmonary Disease (COPD) Products under Development by Companies 26
Chronic Obstructive Pulmonary Disease (COPD) Products under Investigation by Universities/Institutes 40
Chronic Obstructive Pulmonary Disease (COPD) Companies Involved in Therapeutics Development 41
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Assessment 150
Drug Profiles 170
Chronic Obstructive Pulmonary Disease (COPD) Recent Pipeline Updates 449
Chronic Obstructive Pulmonary Disease (COPD) - Dormant Projects 546
Chronic Obstructive Pulmonary Disease (COPD) Discontinued Products 568
Chronic Obstructive Pulmonary Disease (COPD) Product Development Milestones 574
Appendix 583
About ResearchMoz
ResearchMoz is the worlds fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMozs service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Latest Press-Releases: http://www.researchmoz.us/pressrelease